Rapidly Destructive Coxarthrosis as a Potential Side Effect of Crizotinib in a Patient with ROS1-Positive Lung Adenocarcinoma

A 75-year-old woman was diagnosed with c-ros oncogene 1 (ROS1)-positive lung adenocarcinoma. She was treated with crizotinib 750 mg/day for 4.5 years, with partial tumor response. However, the patient subsequently presented with right hip pain and difficulty in walking. She underwent magnetic resona...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ther Clin Risk Manag
Main Authors: Takamori, Shinkichi, Seto, Takashi, Jinnouchi, Mikako, Oba, Taro, Yamaguchi, Masafumi, Takenoyama, Mitsuhiro
Format: Artigo
Sprog:Inglês
Udgivet: Dove 2020
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6975501/
https://ncbi.nlm.nih.gov/pubmed/32021222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S229860
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker